Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Study to Evaluate the Actual Use of Elidel® in South and East Asian Patients From 3 Months to 12 Years With Mild to Moderate Atopic Dermatitis.

NCT06052995 is registered in ClinicalTrials.gov with BGP Products Operations GmbH, a Viatris company as lead sponsor.

NCT NCT06052995
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06052995 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Study to Evaluate the Actual Use of Elidel® in South and East Asian Patients From 3 Months to 12 Years With Mild to Moderate Atopic Dermatitis.
Lead sponsor
BGP Products Operations GmbH, a Viatris company
Phase
Observational
Overall status
Active, not recruiting
Start date
October 15, 2024
Completion date
March 31, 2027
Enrollment
130 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

mild to moderate atopic dermatitis